Soham D. Puvvada
Experienced in Cardiac Tamponade

Dr. Soham D. Puvvada

Internal Medicine
Duke University Medical Ctr, Division Of Medical Oncology 441 Sealy G Mudd Building, 
Durham, NC 
Experienced in Cardiac Tamponade
Duke University Medical Ctr, Division Of Medical Oncology 441 Sealy G Mudd Building, 
Durham, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Soham Puvvada is a primary care provider, practicing in Internal Medicine in Durham, North Carolina. Dr. Puvvada is rated as an Experienced provider by MediFind in the treatment of Cardiac Tamponade. Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, and Small Lymphocytic Lymphoma (SLL).

Her clinical research consists of co-authoring 33 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Cardiac Tamponade.

Specialties
Internal Medicine
Licenses
Internal Medicine in NC
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Duke University Medical Ctr, Division Of Medical Oncology 441 Sealy G Mudd Building, Durham, NC 27710

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase I/Ib Study of Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide and/or Bendamustine
A Phase I/Ib Study of Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide and/or Bendamustine
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Drug
Study Drugs: Bendamustine, Cyclophosphamide
Study Phase: Phase 1
A Phase II, Open-Label Study of Bortezomib (Velcade), Cladribine and Rituximab (VCR) in Advanced, Newly Diagnosed and Relapsed/Refractory Mantle Cell and Indolent Lymphomas
A Phase II, Open-Label Study of Bortezomib (Velcade), Cladribine and Rituximab (VCR) in Advanced, Newly Diagnosed and Relapsed/Refractory Mantle Cell and Indolent Lymphomas
Enrollment Status: Completed
Publish Date: December 30, 2019
Intervention Type: Drug
Study Phase: Phase 2
Phase II Trial Of Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy After Cytoreduction With ESHAP Chemotherapy In Patients With Relapsed Follicular Non-Hodgkin's Lymphoma
Phase II Trial Of Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy After Cytoreduction With ESHAP Chemotherapy In Patients With Relapsed Follicular Non-Hodgkin's Lymphoma
Enrollment Status: Completed
Publish Date: September 04, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Exploratory Study of PXD-101(Belinostat) Followed by Zevalin in Patients With Relapsed Aggressive High-Risk Lymphoma
A Phase II Exploratory Study of PXD-101(Belinostat) Followed by Zevalin in Patients With Relapsed Aggressive High-Risk Lymphoma
Enrollment Status: Completed
Publish Date: August 28, 2018
Intervention Type: Biological, Drug, Radiation
Study Phase: Phase 2
Phase II Study of Brentuximab Vedotin in Combination With Bendamustine and Rituximab, in Patients With CD30 Positive, Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (NHL)
Phase II Study of Brentuximab Vedotin in Combination With Bendamustine and Rituximab, in Patients With CD30 Positive, Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (NHL)
Enrollment Status: Withdrawn
Publish Date: May 19, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

33 Total Publications

Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02.
Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02.
Journal: Advances in therapy
Published: October 10, 2024
Similar Doctors
Experienced in Cardiac Tamponade
Dr. Monica Bapna
Internal Medicine
Experienced in Cardiac Tamponade
Dr. Monica Bapna
Internal Medicine

Apogee Medical Group North Carolina

1705 Tarboro St Sw, 
Wilson, NC 
 (58.9 miles away)
252-399-8040
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Monica Bapna is a primary care provider, practicing in Internal Medicine in Wilson, North Carolina. Dr. Bapna is rated as an Experienced provider by MediFind in the treatment of Cardiac Tamponade. Her top areas of expertise are Subacute Thyroiditis, Cardiac Tamponade, Lymphofollicular Hyperplasia, and Interstitial Nephritis. Dr. Bapna is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Puvvada's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile